Ni(II) complexes bearing an o-bis(aryl)phosphinophenolate ligand were synthesized as catalysts for copolymerization of ethylene and alkyl acrylates. When the P-bound aryl group was 2,6-dimethoxyphenyl group, one of the oxygen atoms in the methoxy groups coordinated to the nickel center on its apical position. This complex was a highly active catalyst without any activators to give highly linear and high molecular weight copolymers. The structures of the copolymers were determined by H andC NMR to clarify that the alkyl acrylate comonomers were incorporated in the main chain and that the structures of the copolymers were significantly influenced by the structure of the aryl group in the ligand.
Nickel
complexes bearing bidentate alkylphophine–phenolate
ligands were synthesized and applied to the polymerization of propylene
and the copolymerization of propylene and polar monomers. Therein,
the use of bulky alkyl substituents on the phosphorus atom was crucial
for the formation of highly regioregular polypropylenes. Theoretical
calculations suggested that the 1,2-insertion of propylene is favored
over the 2,1-insertion in these nickel-catalyzed (co)polymerization
reactions. The substituent at the ortho position
relative to the oxido group greatly influences the polymerization
activity, the molecular weight, and stereoregularity of the polypropylenes.
This method delivers moderately isotactic ([mm] ≤
68%) crystalline polypropylenes. The present system represents the
first example for a nickel-catalyzed regiocontrolled copolymerization
of propylene and polar monomers such as but-3-en-1-ol, but-3-en-1-yl
acetate, and tert-butyl allylcarbamate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.